Drug Information

Drug General Information
Drug ID
D04ALU
Former ID
DIB018208
Drug Name
[3H](+)-cis-diltiazem
Synonyms
[3H]-(+)-cis-diltiazem
Drug Type
Small molecular drug
Indication Discovery agent Investigative [539635]
Structure
Download
2D MOL
Formula
C22H26N2O4S
InChI
InChI=1S/C22H26N2O4S/c1-15(25)28-20-21(16-9-11-17(27-4)12-10-16)29-19-8-6-5-7-18(19)24(22(20)26)14-13-23(2)3/h5-12,20-21H,13-14H2,1-4H3
InChIKey
HSUGRBWQSSZJOP-UHFFFAOYSA-N
PubChem Compound ID
3076
PubChem Substance ID
4556838, 8151955, 10522522, 10589367, 11335179, 11360418, 11363138, 11365700, 11368262, 11374982, 11376424, 11461390, 11485548, 11489552, 11493076, 11494058, 14879942, 29222221, 47476379, 47550480, 47846442, 47995763, 50100216, 50100217, 50855580, 85245799, 85789652, 88977023, 103094892, 103154421, 104011325, 104302456, 104829104, 117600280, 118491175, 124960914, 125350387, 128108067, 135049062, 135265001, 135651160, 142577305, 143684696, 144239374, 162873103, 164808988, 174006614, 179039636, 184530473, 221672747
Target and Pathway
Target(s) Voltage-dependent L-type calcium channel subunit alpha-1C Target Info Inhibitor (gating inhibitor) [531424]
Cav1.1 Target Info Inhibitor (gating inhibitor) [534360]
KEGG Pathway MAPK signaling pathway
Calcium signaling pathway
cGMP-PKG signaling pathway
cAMP signaling pathway
Cardiac muscle contraction
Adrenergic signaling in cardiomyocytes
Vascular smooth muscle contraction
Circadian entrainment
Long-term potentiation
Retrograde endocannabinoid signaling
Glutamatergic synapse
Cholinergic synapse
Serotonergic synapse
GABAergic synapse
Dopaminergic synapse
Insulin secretion
GnRH signaling pathway
Oxytocin signaling pathway
Type II diabetes mellitus
Alzheimer's disease
Amphetamine addiction
Hypertrophic cardiomyopathy (HCM)
Arrhythmogenic right ventricular cardiomyopathy (ARVC)
Dilated cardiomyopathy
NetPath Pathway IL2 Signaling Pathway
PANTHER Pathway Alzheimer disease-amyloid secretase pathway
Nicotinic acetylcholine receptor signaling pathway
5HT2 type receptor mediated signaling pathway
Beta1 adrenergic receptor signaling pathway
Beta2 adrenergic receptor signaling pathway
Oxytocin receptor mediated signaling pathway
Nicotine pharmacodynamics pathway
PathWhiz Pathway Muscle/Heart Contraction
Reactome Adrenaline,noradrenaline inhibits insulin secretion
NCAM1 interactions
Regulation of insulin secretion
WikiPathways Calcium Regulation in the Cardiac Cell
Arrhythmogenic Right Ventricular Cardiomyopathy
Alzheimers Disease
NCAM signaling for neurite out-growth
Integration of energy metabolism
Nicotine Activity on Chromaffin Cells
References
Ref 539635(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2512).
Ref 531424SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes. J Pharmacol Exp Ther. 1990 Nov;255(2):600-7.
Ref 534360High-affinity binding of DTZ323, a novel derivative of diltiazem, to rabbit skeletal muscle L-type Ca++ channels. J Pharmacol Exp Ther. 1997 Apr;281(1):173-9.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.